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Yawning associated with anterior chest pain in
a patient with asthma.
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Abstract : We present a case of a patient with asthma who developed yawning associ-
ated with anterior chest pain. She was admitted due to severe anterior chest pain,
wheezing and dyspnea. Although the frequency of the symptoms decreased, she be-
gan to experience frequent episodes of yawning at night accompanied by tears. While
she experienced yawning, although PEF (peak expiratory flow) decreased, no asth-
matic symptoms, such as wheezing or dyspnea were observed. The yawning was im-
proved markedly by bronchodilators and a leukotriene receptor antagonist, and moder-
ately improved by corticosteroids. We speculated that yawning is a clinical manifesta-
tion of asthma that responds to treatment.
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Case Report
A 54-year-old woman was admitted to our
hospital in February 1993, due to severe ante-
rior chest pain, wheezing and dyspnea. She ex-
perienced sudden chest pain that gradually be-
came more severe, accompanied by vomitting,
wheezing, coughing and dyspnea. She had been
asymptomatic until two years prior to admission,
when wheezing and dyspnea began. Her serum
IgE level was 2139 IU/ml, and both a skin test
and a radioallergosorbent test (RAST) were
positive against house dust mites. According to
episodic symptoms of wheezing and dyspnea,
the patient showed a reversible airway response
with an increase in forced expiratory volume in
one second (FEY1) exceeding 20% in response
to /32-agonist and showed increased bronchial
hyperresponsiveness to methacholine (PC20 ; the
concentration of methacholine causing a 20%
decline of FEY1, 390 fJ. g/mn. She was diag-
nosed as having bronchial asthma. Other poten-
tial causes of the chest pain were ruled out ac-
cording to the findings of upper gastrointestinal
endoscopy, chest radiography, chest computed
tomography, electrocardiogram and ultrasonic
cardiography. Coronary angiography also failed to
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Table I. Symptom Characteristics
Wheezing and Anterior chest Yawnina
dyspnea pam
(.....-), The symptoms completely diuppcared or were markedly
improved
(+) moderately improved
(!J slightly improved
(.) no chanae
LTRA: leukotriene receptor antaaonist
DSCG disodium cromoilyc.te
NSAIDs: nonsteroidal anti-innammatory druas
nitric oxide, adrenocorticotropic hormone-re-
lated peptides and oxytocin. Opioid peptides are
known to inhibit yawning (2). Despite recent
progress, little is known of the neurochemical
mechanisms underlying yawning at the central
level. The administration of dexamethasone al-
tered yawning behavior induced by cholinergic
but not dopaminergic agonists (3). Further re-
search is needed to identify these factors.
Asthma shows a wide variety of clinical man-
ifestations, one of which is chest pain. Three
reported cases of chest pain variant asthma have
suggested its importance as a clinical entity for
patients who initially present with chest pain.
Two patients required a short course oral
corticosteroid treatment to achieve symptom ab-
lation (4). Asthma symptoms (cough, dyspnea,
wheeze, chest tightness, sputum production
and nocturnal awakening) correlated poorly with
the level of airway obstruction (5). However,
the present case developed nocturnal yawning
associated with noncardiac and nonesophageal
chest pain and airway obstruction. The reason
for the occurrence of yawning and chest pain
remains obscure, but the autonomic nerve
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minutes
(+) (++)
(+) (++)
(+) (+)
(+) (++)
(~) (:e)
(++) (.)
More frequently Only at night
at nigbt than
durina daytime
Indefinite For 30 to 40
More tban 2-3 Only one time at
times per day night
Slightly Moderately
Age at onset 61
TIme when they At any time
Duration Indefinite
Frequency Often
Fall 10 PEF Markedly
Effects of
treatments
P2·.gonis! (++)
amInophylline (++)
corticosteroid (++)
LTRA (++)
DSCG (+)
NSAIDs (-)
reveal either stenosis or atherosclerotic changes.
Gastroesophageal reflux disease was also con-
cluded to be an unlikely cause of the chest pain
given that a proton pump inhibitor was not ef-
fective in reducing the chest pain. After being
admitted, she was treated with corticosteroids,
nebulized (i 2-agonist and intravenous aminoph-
ylline for her wheezing and dyspnea, and a
nonsteroidal anti-inflammatory suppository for
the chest pain.
Following discharge, although the frequency
of chest pain decreased, she began to experi-
ence frequent episodes of yawning at night ac-
companied by tears. Her yawning occurred
once every thirty to forty minutes, especially on
cold nights from November to March with no
sensation of dyspnea or chest pain. Her pulmo-
nary function was normal (114.5% of predicted
forced vital capacity (FVC) , 113.8% of pre-
dicted FEV I) when she was asymptomatic.
While she experienced yawning, although PEF
(peak expiratory flow) decreased somewhat (50-
80% of her maximum level), no asthmatic sy-
mptoms, such as wheezing or dyspnea were
observed. The yawning was improved markedly
by bronchodilators and a leukotriene receptor
antagonist, and moderately improved by cortic-
osteroids. In summary, three different symptoms,
namely wheezing and dyspnea, anterior chest
pain and yawning, were observed in the present
case. The characteristics of each symptom are
summarized in Table 1.
Yawning is a complex behavioral event that
depends largely on the autonomic nervous syst-
em, which has been reported to be associated
with a sympathetic suppression that favours a
parasympathetic dominance (1). Yawning is un-
der the control of several neurotransmitters and
neuropeptides at the central level. Substances
that induce yawning include dopamine, excita-
tory amino acids, acetylcholine, serotonin,
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system mayhaveplayedanimpo血Itrolein
血eiroccu汀enCe.Ourcasesuggests仙atyawn-
ingisaclinicalmanifestationofasthmathatre-
spondstotreatment.
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胸部痛,嘱鳴,呼吸困難は徐々に軽快傾向であっ
たが,夜間流涙を伴う あ`くび が頻回に出現す
るようになった｡ あ`くび'が出現する時には,
職息症状 (職場,呼吸困難)は伴わないが,ピー
クフローに低下を認めた｡ あ`くび'に対する治
療としては,気管支拡張剤,ロイコトリエン受容
体結抗剤は著効,副腎皮質ステロイド剤は中等度
有効であった｡ あ`くび'は治療に反応する嘱息
の-症状であることが示唆された｡
